Lupus Foundation of America Awards Four Grants Supporting Early Career Scientists, Funding Critical Areas of Research

2022-12-01

WASHINGTON, Dec. 1, 2022 /PRNewswire/ -- The Lupus Foundation of America is pleased to announce the recipients of the 2022 Gary S. Gilkeson Career Development Award (CDA). The two-year grant supports early career scientists studying important areas of lupus research, while providing mentorship and guidance, helping continued professional growth that builds the lupus research field.

The 2022 recipients are:

Tala El Tal, MD, Hospital for Sick Children

Yevgeniya Gartshteyn, MD, Columbia University

Rufei Lu, MD, PhD, The Regents of the University of California, San Francisco

Rachel Randell, MD, Duke University

"The Lupus Foundation of America's Gary S. Gilkeson Career Development Award continues to play an important role in growing the number of lupus-focused researchers by supporting them with funding and mentorship during this pivotal time in their career. These early career scientists bring a fresh perspective and drive to lupus research that have the promise to lead to the next breakthrough, a better understanding of lupus and innovative treatments," shared Karen H. Costenbader, MD, MPH, Chair of the Lupus Foundation of America's Medical-Scientific Advisory Council.

This year's grantees will focus their research on pediatric lupus, neuropsychiatric lupus and cognitive challenges, and potential new treatment pathways. Each grantee works with an established clinical scientist as a mentor.

"The Lupus Foundation of America's Gary S. Gilkeson Career Development Award encourages young investigators to engage in lupus research early in their careers, setting the stage for their long-term commitment in the field," shared Laura Schanberg, MD, professor of pediatrics, Duke University Medical Center, one of this year's grantee mentors. "The grant not only provides the opportunity and funding for young scientists to pursue research, but it ensures they receive the support and guidance needed from experienced mentors."

The 2022 Career Development Award recipients are committed to advancing the field by studying the following important areas of lupus research:

Tala El Tal, MD, will study cognitive impairment in children and adolescents with lupus. The study will help improve the understanding of possible links between other lupus factors and cognitive impairment in pediatric patients, and how it affects children and adolescents over time as their brains develop.

Yevgeniya Gartshteyn, MD, PhD, will study T-cell subtypes as a potential treatment pathway for lupus. While many lupus treatments target T-Cells, part of the immune system that normally fights infection, this study will look at subtypes to better understand how they work to be able to design better treatments.

Rufei Lu, MD, PhD, will be looking at the potential causes of neurological lupus symptoms, such as confusion and anxiety disorders. The research aims to create an enhanced understanding of how unhealthy immune cells attack the cells in the brain. This could pave the way for future studies and the development of potential therapies for people with lupus with neurological complications.

Rachel Randell, MD, aims to improve medication taking behaviors among children and adolescents with lupus. The study will help further the understanding of factors associated with taking medications correctly, as well as the feasibility of using an app to measure medication taking as prescribed to improve patient health over time.

Each research study by the CDA grantees will strategically advance the Foundation's research agenda, which includes serving as the leader in supporting childhood lupus research. Established in 2006, the LFA's Michael Jon Barlin Childhood Lupus Research Program is the first and only national childhood lupus research program, and calls on some of the greatest minds in the field to address the most urgent challenges in this area of medicine.

Learn more about the Gary S. Gilkeson Career Development Award and its 2022 grantees, here.

About Lupus

Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose, hard to live with and a challenge to treat. Lupus is a cruel mystery because it is hidden from view and undefined, has a range of symptoms, strikes without warning, and has no known cause and no known cure. Its health effects can range from a skin rash to a heart attack. Lupus is debilitating and destructive and can be fatal, yet research on lupus remains underfunded relative to diseases of similar scope and devastation.

About the Lupus Foundation of America

The Lupus Foundation of America is the national force devoted to solving the mystery of lupus, one of the world's cruelest, most unpredictable and devastating diseases, while giving caring support to those who suffer from its brutal impact. Through a comprehensive program of research, education, and advocacy, we lead the fight to improve the quality of life for all people affected by lupus. Learn more about the Lupus Foundation of America at lupus.org.

Media Contact

Mike Donnelly

[email protected]

SOURCE Lupus Foundation of America